Enhancer ID: | E_02_0395 |
Species: | human |
Position : | chr5:138462782-138464782 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Head and neck squamous cell carcinoma |
Pubmed ID: | 30396177 |
Enhancer experiment: | TCGA RNAseq,Immunohistochemical analysis, overexpression vector transfection,Quantitative real-time PCR (qPCR),Western blot,Matrigel invasion assay,Promoterluciferase assay,Chromatin immunoprecipitation (ChIP) analysis |
Enhancer experiment description: | Our data suggests that EGR1 prevents HNSCC metastasis through downregulation of MMP9 and MDM2. EGR1 might be a potential candidate to attenuate HNSCC metastasis. |
Target gene : | EGR1 |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Our data suggests that EGR1 prevents HNSCC metastasis through downregulation of MMP9 and MDM2. EGR1 might be a potential candidate to attenuate HNSCC metastasis. |
TF name : | -- |
TF experiment: | TCGA RNAseq,Immunohistochemical analysis, overexpression vector transfection,Quantitative real-time PCR (qPCR),Western blot,Matrigel invasion assay,Promoterluciferase assay,Chromatin immunoprecipitation (ChIP) analysis |
TF experiment description: | Our data suggests that EGR1 prevents HNSCC metastasis through downregulation of MMP9 and MDM2. EGR1 might be a potential candidate to attenuate HNSCC metastasis. |
Enhancer function : | Our data suggests that EGR1 prevents HNSCC metastasis through downregulation of MMP9 and MDM2. EGR1 might be a potential candidate to attenuate HNSCC metastasis. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Our data suggests that EGR1 prevents HNSCC metastasis through downregulation of MMP9 and MDM2. EGR1 might be a potential candidate to attenuate HNSCC metastasis. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|